Sign In |Help & Support
HOMECHINA STANDARDSICS CLASSIFICATIONINDUSTRY CLASSIFICATIONCHINESE CLASSIFICATIONCART(0)
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)
  1. HOME
  2. Standards for the tumor

the tumor

the tumor, Total:52 items.

The international standard classification for "the tumor" includes: Occupational safety. Industrial hygiene , Medical Sciences and health care facilities in general , Quality , Laboratory medicine .

The Chinese standard classification for "the tumor" includes: Diagnostic standard for occupational diseases , Sanitation in general , Medical science , Computer application , Medical laboratory equipment .

Occupational Health Standard of the People's Republic of China

Anhui Provincial Standard of the People's Republic of China

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB 16386-1996 Diagnostic criteria and principles of management of radiogenic neoplasms
  • GBZ 94-2017 Diagnosis of Occupational Tumors
  • GBZ 97-2017 Judgment standard for occupational radiogenic neoplasms

Group Standards of the People's Republic of China

  • T/CACM 1217-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Pancreatic cancer
  • T/CHSA 004-2020 Guidelines for pathological diagnosis of salivary gland tumors
  • T/GDNAS 011-2022 Prevention and nursing of hand-foot syndrome associated with tumor chemotherapy
  • T/CACM 1261-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Bladder carcinoma
  • T/CHIA 18-2021 Standard for dataset of cancer registration in China
  • T/CACM 1291-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Malignant Lymphoma
  • T/GDNAS 006-2022 Prevention and nursing care of PICC-related thrombosis in cancer patients
  • T/CACM 1243-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Multiple Myeloma
  • T/ZGCMITT 007-2022 National Health and Medical Commission "Tumor Ablation Therapy Technical Management Regulations" Implementation Rules
  • T/GDNAS 014-2022 Standardized nursing assessment of patients prior to cancer chemotherapy
  • T/ZYYX 001-2019 Technical specification for transurethral plasma resection of bladder tumors
  • T/CACM 1172-2019 Clinical guidelines for diagnosis and treatment of oncology in TCM Cervical Cancer

Jiangsu Provincial Standard of the People's Republic of China

  • DB32/T 4007-2021 Tumor high-throughput gene sequencing technical specifications
  • DB32/T 4200-2022 Quality control specification of tumor radiaotherapy
  • DB32/T 4199-2022 Department setting specifications of tumor radiaotherapy in medical institutions

Shanxi Provincial Standard of the People's Republic of China

  • DB14/T 2992-2024 Standards for multidisciplinary diagnosis and treatment of medical oncology

国家卫生计生委

  • WS/T 559-2017 Dietary guidance for patients with malignant tumors

Professional Standard - Agriculture

National Health Commission of the People's Republic of China

  • GBZ 97-2002 Diagnostic criteria for radiogenic neoplasms

中华人民共和国国家卫生和计划生育委员会

  • WS/T 555-2017 Subjective overall nutritional assessment in cancer patients

Guangdong Provincial Standard of the People's Republic of China

Jilin Provincial Standard of the People's Republic of China

  • DB22/T 2367-2015 Regulations for the management of clinical application of antineoplastic drugs
  • DB22/T 3567-2023 Tumor gene mutation detection—high-throughput sequencing technology specifications
  • DB22/T 1862-2013 Hygienic protection norms for the application of antineoplastic drugs

Jiangxi Provincial Standard of the People's Republic of China

  • DB36/T 1788-2023 Tumor registration reporting and management practices for medical institutions

Beijing Provincial Standard of the People's Republic of China

Professional Standard - Hygiene

  • WS 372.6-2012 Basic dataset of disease management—Part 6:Cancer case management

Professional Standard - Medicine

  • YY/T 1175-2010 Quantitative detection reagent(kit) for tumor markers—Chemiluminescent immunoassay

卫生健康委员会

  • WS/T 459-2018 Common used serum tumor marker tests:clinical practice and quality management

RU-GOST R

the tumor,tumor immunity,tumor immunity,tumor data,Tumor week,tumor front,Tumor week,immune tumor,tumor tumor,tumor antigen,deuterium tumor,Tumor week,flow + tumor,tumor reagent,tumor reagent,tumor spread,immune tumor,Immuno-oncology tumor,Antitumor Drugs|Tumor|Tumor Pharmacodynamics|Tumor Diagnosis and Treatment|Tumor Cells|New Antitumor Drugs

All Rights Reserved © 2026 WWW.CHINASTANDARDS.NET visa master american express unionpay apple pay paypal google pay